Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Pharmacotherapy|May 6, 2017
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart FailureJordan B King, Rashmee U Shah, Amy Sainski-Nguyen, et al.Journal of Clinical Lipidology|February 20, 2016
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United StatesSudhir K Unni, Ruben G W Quek, Joseph Biskupiak, et al.Journal of Managed Care & Specialty Pharmacy|November 22, 2021
Payer perceptions on the use of patient-reported outcomes in oncology decision makingGary Oderda, Diana Brixner, Joseph Biskupiak, et al.Journal of Medical Economics|January 5, 2021
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United StatesBeilei Cai, Zheng-Yi Zhou, Weiguang Xue, et al.Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.Future Cardiology|January 31, 2022
Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy riskConnor Willis, Alexandre H Watanabe, Justin Hughes, et al.Journal of Managed Care & Specialty Pharmacy|February 3, 2024
The impact of a statewide insulin copay cap policy for insured patients with diabetes in UtahNiying Li, Rupesh Panchal, Theodoros Giannouchos, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experimentRupesh Panchal, Danielle Nguyen, Priyanka Ghule, et al.Cancer Research Communications|March 24, 2026
Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesChia Jie Tan, Connor Willis, Timothy Bell, et al.Journal of Managed Care & Specialty Pharmacy|May 26, 2018
Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer PerspectiveRohit Mistry, Jessica R May, Gaurav Suri, et al.Pageof 5